Re: Li et al.: Long-term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor

October 2018, Volume 2, Issue 10, p. e13-e14
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: October 3, 2018

Guidelines on diabetic eye care. the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings

September 2018, Volume 8, Issue 9, pp.22645-22646
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: September 29, 2018

Vision Outcomes Following Anti–Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice

September 2018, Volume 193, p. 253–254
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: September 1, 2018

Comment on “Management strategies in malignant glaucoma secondary to antiglaucoma surgery”

August 2018, Volume 11, Issue 8, p. 1433-1434
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: August 7, 2018

Correspondence

August 2018, Volume 38, Issue 8, p. e69–e71
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: August 6, 2018

What We Have Learned From the Ocular Hypertension Treatment Study

August 2018, Volume 192, p. 248–249
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: August 2, 2018

The fate of eyes with wet AMD beyond 4 years of anti-VEGF therapy

August 2018, Volume 256, Issue 8, pp 1551–1552
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: August 1, 2018

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

July, 2018, Volume 10, Issue 7, pp.71192-71193
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 12, 2018

Sustained benefits from ranibizumab for central retinal vein occlusion with macular edema: 24-month results of the crystal study

July 2018, Volume 10, Issue 7, pp.71828-71829
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 11, 2018

Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management

July 2018, Volume 11, Issue 7, pp 1173-1178
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: July 10, 2018

Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success

July 2018, Volume 256, Issue 7, pp 1353–1354
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: June 19, 2018

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study

June 2018, Volume 256, Issue 6, pp 1209–1210
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: May 19, 2018

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment

May 2018, Volume 256, Issue 5, pp. 1035–1037
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: May 2, 2018

Outcomes of Patients Initially Treated with Intravitreal Bevacizumab for Central Retinal Vein Occlusion: Long-Term Follow-Up

May 2018, Volume 33, Issue 3, p.318-319
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: May 1, 2018

Aflibercept for patients with neovascular age-related macular degeneration in routine clinical practice in Germany. Twelve-month outcomes of Perseus

April 2018, Volume 10, Issue 4, pp.68602-68603
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: April 23, 2018

Letter to the Editor: Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial

March 2018, Volume 49, Issue 3, p. 160
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: March 21, 2018

Re: Khurana et al.: Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study (Ophthalmol Retina. 2017)

March 2018, Volume 2, Issue 3, p. e5–e6
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: March 2, 2018

Inner nuclear layer cystoid spaces are a poor prognostic factor in typical age-related macular degeneration and polypoidal choroidal vasculopathy

March 2018, Volume 256, Issue 3, pp. 627–629
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: March 1, 2018

Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome

February 2018, Volume 186, p.164–165
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: Feb 1, 2018

Comments to: Restoration of photoreceptors in eyes with diabetic macular edema.

January 2018, Volume 28, Issue 1, pp. 132-133
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: January 5, 2018

Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy

January 2018, Volume 256, Issue 1, pp. 233–235
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: January 3, 2018

Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy

January 2018, Volume 256, Issue 1, pp. 221–223
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: January 3, 2018

Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion

December 2017, Volume 184, p.190–191
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: December 1, 2017

Comments to: Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal

Nov-Dec 2017, Volume 27, Issue 6, pp. 627 - 800, e175 - e195
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: November 13, 2017

Correspondence

November 2017 - Volume 37 - Issue 11 - p e139–e141
Dan Călugăru, Mihai Călugăru
University of Medicine Cluj-Napoca, Romania
Published online: November 11, 2017

Bun venit!

Cu entuziasm și profesionalism, Dr. Dan CĂLUGĂRU a format o echipă bine pregătită, care având la dispoziție tehnică medicală performantă, ajută la rezolvarea problemelor oftalmologice, punând întotdeauna accent pe confortul și siguranța pacienților, oferind servicii oftamologice complete la standarde înalte de calitate, atât prin experiența profesională cât și ca nivel al dotării cu aparatură. Echipa beneficiază de suportul și experiența Prof. Univ. Dr. Mihai Călugăru.

În clinica noastră se tratează peste 3000 de pacienți anual, număr în permanentă creștere, având în vedere progresul științific și tehnic de care echipa Dr. Călugăru este mereu preocupată.

Echipamentele noaste sunt furnizate de către producători consacrați în domeniu: Alcon (S.U.A), Bausch & Lomb (SUA), Blanco (Germania), Brumaba (Germania), Carl Zeiss Meditec (Germania), Spacelabs (S.U.A), Getinge (Suedia), Tomey (Japonia), Melag (Germania), Nidek (Japonia), Briot (Belgia).

Pentru operațiile de reducere a dioptriilor cu laser excimer (Lasek, Prk) nu este nevoie de analize. Pentru toate celelalte intervenții chirurgicale analizele sunt obligatorii.

Analizele necesare pentru operație:

  • Hemoleucograma
  • Coagulograma
  • Glicemie
  • Uree
  • VSH
  • AST
  • ALT
  • Bilirubina totală
  • HVB
  • HVC
  • HIV
  • Consult cardiologic
  • EKG

Pentru a reuși vindecarea unui număr cât mai mare de pacienți echipa Dr. Călugăru colaborează cu mai mulți medici specializați în oftalmologie, opticieni și optometriști, cât și cu medicii de familie din zonele învecinate.